Clinical Trial Update: Pramipexole to Target "Anhedonic Depression" [Phase 2]

View source ↗

Summary

Phase 2 trial of pramipexole for anhedonic depression has been completed, evaluating its effects in bipolar and unipolar depression. Results were posted on 2025…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Persistent Depressive Disorder

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Region Skane | Conditions: Depression, Bipolar, Depression, Unipolar | Phase 2 | Status: COMPLETED | Results posted: 2025-12-12